Levemir is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Detemir.
Product ID | 0169-3687_18faddbd-0bc0-48d1-a16f-f4939de3d0a3 |
NDC | 0169-3687 |
Product Type | Human Prescription Drug |
Proprietary Name | Levemir |
Generic Name | Insulin Detemir |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2006-03-27 |
Marketing Category | BLA / NDA |
Application Number | BLA021536 |
Labeler Name | Novo Nordisk |
Substance Name | INSULIN DETEMIR |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2006-03-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA021536 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2006-03-27 |
Ingredient | Strength |
---|---|
INSULIN DETEMIR | 100 [iU]/mL |
SPL SET ID: | d38d65c1-25bf-401d-9c7e-a2c3222da8af |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0169-3687 | Levemir | insulin detemir |
0169-6432 | Levemir | insulin detemir |
0169-6438 | Levemir | insulin detemir |
50090-1276 | Levemir | insulin detemir |
50090-1475 | Levemir | insulin detemir |
50090-4501 | Levemir | insulin detemir |
68258-8977 | Levemir | insulin detemir |
70518-1387 | Levemir | insulin detemir |
70518-1462 | Levemir | insulin detemir |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LEVEMIR 76468735 2808088 Live/Registered |
Novo Nordisk A/S 2002-11-07 |